This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter

STEWARTVILLE, Minn., May 21, 2012 /PRNewswire/ -- Rochester Medical Corporation (NASDAQ:ROCM) is pleased to announce an addition to its Magic3 Intermittent Catheter line with the launch of the Magic3 Hydrophilic Intermittent Catheter with Coude Tip and Insertion Sleeve. 

This new catheter is the very latest Magic3 technology. It provides the added benefits of the touch-free gripping device, combined with a specially designed curved tip configuration.

The Coude tip is designed to aid insertion, especially around natural curves within the urethra. Coude tip catheters are often used by men with an enlarged prostate, narrowing of the urethra, or bladder neck contractures. Magic3 intermittent catheters leverage Rochester Medical's proprietary m3 technology to deliver the benefits of a three-layer all-silicone design. They are the first Coude intermittent catheters created and crafted from a composition of three distinct functional layers.  Each uniquely formulated layer independently addresses a particular product attribute required for comfortable, easy, and reliable intermittent catheterization. 

In this new offering, Rochester Medical has incorporated additional important design enhancements. The patent-pending insertion sleeve provides touch-free insertion while allowing the user to firmly grip the catheter surface, making it easier to maneuver. The insertion sleeve is sterilized and located inside the packaging. This new feature is designed to provide the user more control while minimizing risk of contamination while catheterizing. 

Kicking-off a comprehensive sales campaign, Rochester Medical has begun rolling out the new Magic3 Coude in the U.S. via introductions to its distribution partners and targeted clinical call points. 

The Magic3 catheters are available in male (16") length and in diameters ranging from 10Fr to 18Fr.  Most state Medicaid, Medicare, and private insurance companies will cover these advanced catheters; local product suppliers can provide details about specific payor sources. Additional product and ordering information is available by contacting Rochester Medical at 1-800-243-3315 or info@rocm.com.

For over two decades, Rochester Medical Corporation has been developing, manufacturing, and marketing latex-free and PVC-free disposable medical devices for urological and continence care applications. Manufactured in the USA with an environmentally conscious design, the all-silicone Magic3 Intermittent Catheter with Coude Tip and Insertion Sleeve is yet another example of the Company's commitment to providing innovative solutions to address the needs of patients, caregivers, and clinicians.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500.  More information about Rochester Medical is available on its website at http://www.rocm.com.

SOURCE Rochester Medical Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,113.54 +61.81 0.36%
S&P 500 1,983.53 +9.90 0.50%
NASDAQ 4,456.0160 +31.3120 0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs